DCDiana Chavez-Muñoz

Diana Chavez-Muñoz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Diana Chavez-Muñoz has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pharmacologic Strategies for Intraoperative Hypotension When Ephedrine Is Unavailable: An Evidence-Based Review

    by Gilberto Duarte-Medrano, Natalia Nuño-Lámbarri, Diana Chavez-Muñoz, Rebeca Garazi Elguezabal Rodelo, Octavio Gonzalez-Chon, Luigi La Via

    Background/Objectives: Intraoperative hypotension (IOHs) affects up to 87% of patients under general anesthesia and is consistently associated with acute kidney injury, myocardial damage, stroke, and mortality. The intermittent unavailability of ephedrine across healthcare systems underscores the need for evidence-based alternatives. This review critically evaluates pharmacological options for IOH when ephedrine is unavailable, focusing on receptor pharmacodynamics, population-specific evidence, and clinical consequences of inadequately managed hypotension. Methods: A narrative, evidence-based review was conducted examining mechanisms of action, dosing strategies, adverse effect profiles, and clinical applicability of key vasoactive agents: ephedrine, phenylephrine, norepinephrine, and epinephrine. Population-specific evidence across obstetric, pediatric, and elderly cohorts was synthesized from randomized controlled trials, meta-analyses, and observational studies. The clinical impact of IOH on neurological, cardiovascular, and renal outcomes was reviewed. Results: Each vasopressor exhibits a distinct receptor-selectivity profile that determines its hemodynamic effect and optimal clinical context. Norepinephrine’s favorable α1/β1 balance tends to preserve cardiac output better than pure α1-agonists and has emerged as a promising alternative in obstetric and elderly populations, although the optimal agent ultimately depends on the underlying mechanism of hypotension and individual patient characteristics. Epinephrine provides combined vasopressor and inotropic support for hypotension with myocardial depression. IOH is associated with a greater than twofold increase in postoperative AKI and significantly elevated risks of myocardial infarction and stroke, with outcomes driven by cumulative hypotensive exposure rather than isolated pressure nadirs. Conclusions: Effective management of IOH requires individualized vasopressor selection guided by underlying pathophysiology, cardiovascular profile, and surgical context. A physiology-based strategy—rather than protocol-driven drug substitution—enables anesthesiologists to achieve precise hemodynamic control and preserve end-organ perfusion even when ephedrine is unavailable.


  • Open Access

    Pituitary Neuroendocrine Tumors and the Role of Their Pattern of Invasion to Adjacent Structures

    by Diocelina Navarro-Bastida, Sergio Zavala-Vega, Noemi Gelista-Herrera, Natalia Villa-Corral, Diana Chavez-Muñoz, Ricardo Gómez-Rivera, Daniel Rembao-Bojórquez, Martha Tena-Suck, Ciltlaltepetl Salinas-Lara, Lesly Portocarrero-Ortiz, et al.

    Pituitary neuroendocrine tumors (PitNets) are considered benign, but can be invasive. They are classified by their size (microadenomas, macroadenomas, and giant adenomas), by their clinical manifestations (functioning, non-functioning), and by the hormonal content detected by immunocytochemistry. PitNets show slow growth, occupying the sellar region and invading adjacent structures. Their size and invasion have been analyzed using different radiological techniques, complemented by surgical observations and pathological findings. We also include the analysis of the frequency and degree of invasion of functioning and non-functioning PitNets in patients at the National Institute of Neurology and Neurosurgery in Mexico City. The analysis of the size and determination of the invasion degree of PitNets, in relation to the clinical presentation characteristics and hormonal content, allows a better understanding of the behavior of these tumors, which is crucial in planning both the surgical strategy and the follow-up, since size is related to the disease evolution.